Count recovery times and resource usage
| . | DAGO1 . | DAGO1+m . | P value . | DAGO2 . | DAGO2+m . | P value . |
|---|---|---|---|---|---|---|
| Recovery times | ||||||
| Neutrophil recovery to 1 × 109/L, median (95% CI), d | 32 (28-34) | 33 (28-36) | .37 | 32 (30-35) | 33 (30-38) | .40 |
| Platelet recovery to 100 × 109/L, median (95% CI), d | 28 (26-30) | 27 (26-30) | .814 | 29 (27-30) | 28 (27-32) | .580 |
| Resource use, median (IQR) | ||||||
| Units of blood | 8 (6-13) | 10 (7-11) | .445 | 9 (7-12) | 7 (6-9) | .029 |
| Units of platelets | 10 (6.5-14) | 11.5 (8-15) | .406 | 13 (10-17) | 9 (6.5-12) | .001 |
| Days of IV antibiotics | 17 (13-27.5) | 17 (12-26) | .804 | 21 (15-28) | 20 (12-25) | .147 |
| Nights in hospital | 36 (30-40) | 39 (31-50) | .103 | 36 (31-40) | 36 (28-43) | .884 |
| . | DAGO1 . | DAGO1+m . | P value . | DAGO2 . | DAGO2+m . | P value . |
|---|---|---|---|---|---|---|
| Recovery times | ||||||
| Neutrophil recovery to 1 × 109/L, median (95% CI), d | 32 (28-34) | 33 (28-36) | .37 | 32 (30-35) | 33 (30-38) | .40 |
| Platelet recovery to 100 × 109/L, median (95% CI), d | 28 (26-30) | 27 (26-30) | .814 | 29 (27-30) | 28 (27-32) | .580 |
| Resource use, median (IQR) | ||||||
| Units of blood | 8 (6-13) | 10 (7-11) | .445 | 9 (7-12) | 7 (6-9) | .029 |
| Units of platelets | 10 (6.5-14) | 11.5 (8-15) | .406 | 13 (10-17) | 9 (6.5-12) | .001 |
| Days of IV antibiotics | 17 (13-27.5) | 17 (12-26) | .804 | 21 (15-28) | 20 (12-25) | .147 |
| Nights in hospital | 36 (30-40) | 39 (31-50) | .103 | 36 (31-40) | 36 (28-43) | .884 |